Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitethreearchpartners...
Phone(650) 529-8000
Emailinfo@threearchpar...
Employees
Founded1993

Funds

Offices

Portola Valley, USA
3200 Alpine Road
Portola Valley, CA, 94028
USA

People

Partner
Partner
Partner
Co - Founder & Partner
Venture Partner
Venture Partner
Chief Financial Officer

Tags

Three Arch Partners

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.

Recent Milestones

Investments

Company Date Round Size Participants
Ocera Therapeutics 11/2013Venture Round$28M8
Nevro 3/2013Series C$48M9
Access Closure 10/2012Venture Round$998k3
iScience Interventional 1/2012Partial Close$2.76M6
AccessClosure, Inc. 1/2012Venture Round$2.8M2
Nevro 7/2011Venture Round$58M7
Neuronetics 5/2011Series E$30M8
Tibion Bionic Technologies 3/2011Series B$10.2M2
VisionCare Ophthalmic Technologies 1/2011Series E$31M5
TriReme Medical 10/2010Series D$17M3
Ingenuity Systems 7/2010Venture Round$15.4M3
Calistoga Pharmaceuticals 6/2010Series C$40M6
Baxano 6/2010Series C$30M6
Voyage Medical 6/2010Series C$20.6M3
Hemosphere 4/2010Series A$9.3M6
Free & Clear 1/2010Venture Round$10M3
Calibra Medical 11/2009Venture Round$1.4M5
Neuronetics 10/2009Series D$30M8
Visiogen 5/2009Series D$40M7
Calistoga Pharmaceuticals 5/2009Series B$30M4
iScience Interventional 5/2009Series F$20.5M8
SpinalMotion 2/2009Series C$500k4
Cardiac Concepts 10/2008Series B$21M6
APT Pharmaceuticals 9/2008Series A$32M7
NovaSys 5/2008Venture Round$49.5M10
Concert Pharmaceuticals 4/2008Series C$37M12
Cameron Health 3/2008Series E$14M4
Benvenue Medical 1/2008Series B$15M3
TriReme Medical 10/2007Series C$15.5M2
Satiety 7/2007Series D$30M6
NeuroVista 5/2007Series B$33.8M5
Reliant Technologies 4/2007Series E$15M3
Calistoga Pharmaceuticals 3/2007Series A$21M4
Concert Pharmaceuticals 11/2006Series B$48.5M8
Concert Pharmaceuticals 7/2006Series A$10M5
Concuity 4/2006Series E$2.5M2
Allux Medical 8/2005Venture Round$6.4M3
Sirtris Pharmaceuticals 3/2005Series B$27M6
Epocrates 8/2002Series C5
Epocrates 8/2000Series B$35M5

Videos

Sources

  1. Ocera raises $28M for PhIIb liver disease study Read more: Ocera raises $28M for PhIIb liver disease study - FierceBiotech http://www.fiercebiotech.com/story/ocera-raises-28m-phiib-liver-disease-study/2013-11-06#ixzz2jvnEBLHG Subscribe at FierceBiotech (fiercebiotech.com) [edit]
  2. Nevro Raises $48M in Series C Financing (finsmes.com) [edit]
  3. VC funding: Q4 2012 [edit]
  4. iScience Interventional Raises US$2.8 Million In Venture Financing (researchviews.com) [edit]
  5. VC Funding: Q1 2012 [edit]
  6. Nevro Completes $58M Financing (finsmes.com) [edit]
  7. Neuronetics, Inc. Raises $30 Million in Series E Financing (marketwire.com) [edit]
  8. Tibion Corporation Announces New $10 Million Financing Round, New Board Chairman & Board Members (earthtimes.org) [edit]
  9. VisionCare Ophthalmic Technologies Closes $31M Series E Financing (finsmes.com) [edit]
  10. TriReme Medical Announces $17 Million Series D Financing (prnewswire.com) [edit]
  11. Life science startup Ingenuity Systems brings in $15.4M (venturebeat.com) [edit]
  12. Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com) [edit]
  13. Baxano, Inc.: Series C $30M (onbiovc.com) [edit]
  14. Voyage Medical raises $20.6M more for heart treatment devices (venturebeat.com) [edit]
  15. Hemosphere, Inc.: Series A $9.3M (onbiovc.com) []
  16. Free & Clear banks on healthy savings (seattletimes.nwsource.com) [edit]
  17. Calibra takes $1.4M to for insulin delivery devices (venturebeat.com) [edit]
  18. Neuronetics, Inc.: Series D $30M (onbiovc.com) [edit]
  19. Visiogen, Inc.: Series D $40M (onbiovc.com) [edit]
  20. Capital Report Index [edit]
  21. iScience Interventional, Inc.: Series F $20.5M (onbiovc.com) [edit]
  22. VentureBeat (venturebeat.com) [edit]
  23. Cardiac Concepts Raises $21 Million (equityhelpdesk.com) [edit]
  24. APT Pharmaceuticals Secures $32 Million in Series B Financing (aptbio.com) [edit]
  25. Novasys Medical takes $49.5M for women’s medical device (venturebeat.com) [edit]
  26. Capital Funding Report [edit]
  27. Defibrillator maker Cameron Health takes in $14M (venturebeat.com) [edit]
  28. Benvenue Medical Closes $15 Million Series B Financing (benvenuemedical.com) [edit]
  29. TriReme Medical Inc. Announces $15.5 Million Series C Financing (trirememedical.com) [edit]
  30. Satiety pulls in $30M for obesity device (venturebeat.com) [edit]
  31. NeuroVista raises $33.8M in venture capital (seattletimes.nwsource.com) [edit]
  32. Reliant Technologies raises $15M for aesthetic laser and surgery products (venturebeat.com) [edit]
  33. Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing (calistogapharma.com) [edit]
  34. Concert Pharmaceuticals Raises $48.5 Million in Series B Financing (concertpharma.com) [edit]
  35. Concert Pharmaceuticals, Inc.,â„¢ Announces Financing of its Series A Round (concertpharma.com) [edit]
  36. Concuity, Inc. Raises $2.5 Million (findarticles.com) [edit]
  37. EDGAR [edit]
  38. Sirtris Pharmaceuticals closes $27M second round (boston.bizjournals.com) [edit]
  39. otohns.net [edit]
  40. epocrates.com [edit]
Edit This Page
Last Edited 3/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy